Current Signal Transduction Therapy

期刊全称Current Signal Transduction Therapy
期刊缩写CURR SIGNAL TRANSD T
涉及主题生物医学遗传学化学内科学生物化学计算机科学细胞生物学癌症研究物理心理学信号转导基因癌症病理
期刊介绍

In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders. The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders. The journal publishes timely in-depth reviews, research article and drug clinical trial studies in the field of signal transduction therapy. Thematic issues are also published to cover selected areas of signal transduction therapy. Coverage of the field includes genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases. Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.

期刊ISSNprint: 1574-3624 on-line: 2212-389
历年影响因子
2024年 2023年 2022年 2021年 2020年 2019年 2018年 2017年
00000000
历年发表/被引量
年份202620252024202320222021202020192018201720162015
发表量182024192119174158132448
被引量0623163252861372463454137
h-Index15
自引率N.A.
涉及的研究领域医学-药学
中科院2025年分区 ?
大类小类TOP期刊综述期刊
WOS期刊分区

JCR学科分类

JCR分区学科名称收录数据库JCR分区分区排名

JCI学科分类

JCI分区学科名称收录数据库JCI分区分区排名
期刊主页http://benthamscience.com/journal/index.php?journalID=cstt
投稿网址http://benthamscience.com/journal/authors-guidelines.php?journalID=cstt#top
出版商Bentham Science Publishers B.V.
出版国家(地区)U ARAB EMIRATES
出版周期Tri-annual
每年出版文章数19
Gold OA文章占比0.00%
原创研究文献占比
(排除综述)
0.00%
SCI收录类型

Scopus (CiteScore)

PubMed链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1574-3624%5BISSN%5D
平均审稿周期>12周,或约稿
平均录用比例容易
相关链接

您可以在上述网站查看该期刊的网友互动,及期刊影响力的其它指标。

注:上述信息均来源于网络,仅供查考,如有遗漏或信息错误,欢迎 向我反馈